288 related articles for article (PubMed ID: 18583100)
1. In vitro-selected resistance to fluoroquinolones in two Brucella strains associated with mutational changes in gyrA.
Turkmani A; Psaroulaki A; Christidou A; Chochlakis D; Tabaa D; Tselentis Y
Int J Antimicrob Agents; 2008 Sep; 32(3):227-32. PubMed ID: 18583100
[TBL] [Abstract][Full Text] [Related]
2. A nucleotide mutation associated with fluoroquinolone resistance observed in gyrA of in vitro obtained Rhodococcus equi mutants.
Niwa H; Hobo S; Anzai T
Vet Microbiol; 2006 Jun; 115(1-3):264-8. PubMed ID: 16563665
[TBL] [Abstract][Full Text] [Related]
3. Complete nucleotide sequence of the gyrA gene of Helicobacter pullorum and identification of a point mutation leading to ciprofloxacin resistance in poultry isolates.
Pasquali F; Rossi M; Manfreda G; Zanoni R
Int J Antimicrob Agents; 2007 Sep; 30(3):222-8. PubMed ID: 17644320
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.
Lázaro FG; Rodríguez-Tarazona RE; García-Rodríguez JA; Muñoz-Bellido JL
Int J Antimicrob Agents; 2009 Sep; 34(3):252-4. PubMed ID: 19243922
[TBL] [Abstract][Full Text] [Related]
5. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of susceptibility to fluoroquinolones in Bartonella isolates from Australia reveals a natural mutation in gyrA.
Angelakis E; Biswas S; Taylor C; Raoult D; Rolain JM
J Antimicrob Chemother; 2008 Jun; 61(6):1252-5. PubMed ID: 18334491
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
[TBL] [Abstract][Full Text] [Related]
8. Uptake of ciprofloxacin and ofloxacin by 2 Brucella strains and their fluoroquinolone-resistant variants under different conditions. An in vitro study.
Turkmani A; Psaroulaki A; Christidou A; Samoilis G; Mourad TA; Tabaa D; Tselentis Y
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):447-51. PubMed ID: 17920802
[TBL] [Abstract][Full Text] [Related]
9. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
Preisler A; Heisig P
J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
[TBL] [Abstract][Full Text] [Related]
10. Study of isolation of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites.
Zhang W; Wu Y; Yin W; Yu M
Chin Med J (Engl); 2002 Oct; 115(10):1573-5. PubMed ID: 12490114
[TBL] [Abstract][Full Text] [Related]
11. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
[TBL] [Abstract][Full Text] [Related]
12. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
Beeton ML; Chalker VJ; Kotecha S; Spiller OB
J Antimicrob Chemother; 2009 Sep; 64(3):529-38. PubMed ID: 19567408
[TBL] [Abstract][Full Text] [Related]
13. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H
Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532
[TBL] [Abstract][Full Text] [Related]
14. Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure.
Yan M; Sahin O; Lin J; Zhang Q
J Antimicrob Chemother; 2006 Dec; 58(6):1154-9. PubMed ID: 17023497
[TBL] [Abstract][Full Text] [Related]
15. In vitro selection of fluoroquinolone resistance in Brucella melitensis.
Ravanel N; Gestin B; Maurin M
Int J Antimicrob Agents; 2009 Jul; 34(1):76-81. PubMed ID: 19261448
[TBL] [Abstract][Full Text] [Related]
16. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
Guo Y; Pei X; Liu X
Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
[TBL] [Abstract][Full Text] [Related]
17. Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis.
Peterson ML; Rotschafer JC; Piddock LJ
J Antimicrob Chemother; 2003 Sep; 52(3):481-4. PubMed ID: 12917248
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.
Bogaerts P; Berhin C; Nizet H; Glupczynski Y
Helicobacter; 2006 Oct; 11(5):441-5. PubMed ID: 16961806
[TBL] [Abstract][Full Text] [Related]
19. In vivo selection of aac(6')-Ib-cr and mutations in the gyrA gene in a clinical qnrS1-positive Salmonella enterica serovar Typhimurium DT104B strain recovered after fluoroquinolone treatment.
de Toro M; Rojo-Bezares B; Vinué L; Undabeitia E; Torres C; Sáenz Y
J Antimicrob Chemother; 2010 Sep; 65(9):1945-9. PubMed ID: 20639314
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of point mutations in the ygeD, gyrA and parC genes in fluoroquinolones resistant clinical isolates of Chlamydia trachomatis].
Misiurina OIu; Shipitsina EV; Finashutina IuP; Lazarev VN; Akopian TA; Savicheva AM; Govorun VM
Mol Gen Mikrobiol Virusol; 2004; (3):3-7. PubMed ID: 15354934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
